Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950136-07-001632
Filing Date
2007-03-14
Accepted
2007-03-14 16:31:03
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 file1.htm 10-K 4493904
2 SUSIDIARIES OF THE REGISTRANT file2.htm EX-21.1 5055
3 CONSENT OF PUBLIC ACCOUNTING FIRM file3.htm EX-23.1 4201
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) file4.htm EX-31.1 11076
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) file5.htm EX-31.2 11098
6 CERTIFICATION OF CEO PURSUANT TO SECTION 1350 file6.htm EX-32.1 4925
7 CERTIFICATION OF CFO PURSUANT TO SECTION 1350 file7.htm EX-32.2 4936
8 ebox.gif GRAPHIC 58
9 xbox.gif GRAPHIC 63
10 spacer.gif GRAPHIC 43
11 html_05145graph01.jpg GRAPHIC 48458
  Complete submission text file 0000950136-07-001632.txt   4604258
Mailing Address FOUR SCIENCE PARK NEW HAVEN CT 06511
Business Address 4 SCIENCE PARK NEW HAVEN CT 06511 2034984210
VION PHARMACEUTICALS INC (Filer) CIK: 0000944522 (see all company filings)

EIN.: 133671221 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26534 | Film No.: 07693953
SIC: 2836 Biological Products, (No Diagnostic Substances)